Pmv Pharmaceuticals Inc (PMVP NASDAQ) stock market data APIs
$1.4428
-0.06(-4.2%)
as of May 6, 2026
Try our APIs with
free plan!
Pmv Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
Prev. Close
1.4428
Open
1.3786
High
1.4676
Low
1.3763
52 wk Range
0.81-1.88
Market Cap
77 328 K
Shares Outstanding
53 329 K
EPS
0
Beta
1.41
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Pmv Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Pmv Pharmaceuticals Inc data using free add-ons & libraries
Get Pmv Pharmaceuticals Inc Fundamental Data
Pmv Pharmaceuticals Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -86 073 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-08
- EPS/Forecast: -0.3333
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pmv Pharmaceuticals Inc News
New
PMV Pharmaceuticals Announces Board Chair Transition
PRINCETON, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and develop...
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
Enrollment remains on track in Phase 2 pivotal portion of PYNNACLE trial evaluating rezatapopt as monotherapy in platinum-resistant/refractory ovarian cancer patients with a TP53 Y220C mutation Rezata...
CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround
On February 2, BML Capital Management, LLC disclosed a new position in CarMax(NYSE:KMX), acquiring 155,000 shares in an estimated $5.99 million trade based on quarterly average pricing. What happened...
Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter.
On February 2, BML Capital Management disclosed in a Securities and Exchange Commission filing that it sold out of Alumis(NASDAQ:ALMS), liquidating 1,210,415 shares in an estimated $4.83 million trade...
Get Pmv Pharmaceuticals Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
